Home/Filings/4/0001209191-22-033223
4//SEC Filing

Tate Simon 4

Accession 0001209191-22-033223

CIK 0001768446other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 5:17 PM ET

Size

5.4 KB

Accession

0001209191-22-033223

Insider Transaction Report

Form 4
Period: 2022-05-19
Tate Simon
Director
Transactions
  • Award

    Stock Option (Right To Buy)

    2022-05-19+10,00010,000 total
    Exercise: $3.46Exp: 2032-05-18Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest on the earlier of May 19, 2023 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.

Issuer

Eliem Therapeutics, Inc.

CIK 0001768446

Entity typeother

Related Parties

1
  • filerCIK 0001867441

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 5:17 PM ET
Size
5.4 KB